Daiwa Securities Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Sell
6,996
-176
-2% -$15K ﹤0.01% 951
2026
Q1
$618K Buy
7,172
+575
+9% +$51.6K ﹤0.01% 866
2025
Q4
$576K Buy
6,597
+275
+4% +$20.9K ﹤0.01% 860
2025
Q3
$362K Buy
6,322
+1,271
+25% +$73.2K ﹤0.01% 925
2025
Q2
$298K Buy
5,051
+3,819
+310% +$247K ﹤0.01% 919
2025
Q1
$90K Buy
+1,232
New +$102K ﹤0.01% 974
2024
Q2
Sell
-9,300
Closed -$499K 1339
2024
Q1
$499K Hold
9,300
﹤0.01% 839
2023
Q4
$496K Hold
9,300
﹤0.01% 831
2023
Q3
$462K Buy
+9,300
New +$520K ﹤0.01% 842

Other funds holding GMED

Daiwa Securities Group's GMED Position: Q2 2026 in Review

Daiwa Securities Group reduced its Globus Medical (GMED) stake by 2.5% in Q2 2026, selling an estimated $15K and leaving 6,996 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Daiwa Securities Group first reported a position in GMED in Q3 2023 and has held it in 9 quarters since. The position peaked at $618K in Q1 2026. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Daiwa Securities Group held 6,996 shares of Globus Medical worth $553K as of Q2 2026.
  • Daiwa Securities Group sold 176 Globus Medical shares in Q2 2026, an estimated $15K.
  • Globus Medical made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #951 holding.
  • Daiwa Securities Group first reported a position in Globus Medical in Q3 2023 and has held it in 9 quarters since.
  • Daiwa Securities Group's Globus Medical position peaked at $618K in Q1 2026.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.